Related Experiment Video
Updated: Aug 5, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Emerging hypervirulent Klebsiella pneumoniae: Myth, reality, and clinical relevance
Sanika Mahesh Kulkarni1,2, Jobin John Jacob1, Abi Manesh3
1Department of Clinical Microbiology, Christian Medical College and Hospital, Vellore, 632004, India.
Abstract:
The global emergence of hypervirulent Klebsiella pneumoniae (hvKp) has raised concern because of its association with invasive infections and reports of increased mortality. However, recent systematic reviews and meta-analyses reveal a critical paradox: genotypically defined convergent clones and strains carrying fewer virulence-associated markers exhibit mortality rates comparable to, rather than exceeding, those of multidrug-resistant (MDR) K. pneumoniae. In contrast, traditional phenotypic identification preferentially enriches for the classical hypervirulent lineages that remain uniquely associated with metastatic complications. Genome-wide association studies (GWAS) and phenotypic analyses further confirm capsular polysaccharide as a pivotal, plasmid-independent virulence driver in carbapenem-resistant hvKp cohorts, with only 37.3% (22/59) demonstrating true hypervirulence despite universal plasmid marker presence, reinforcing lineage-specific risk over gene carriage alone. The definitional crisis, wherein virulence gene carriage alone fails to predict clinical outcomes, highlights the importance of lineage-specific risk. This is best exemplified by K1/K2 sequence type (ST)23, including clonal group (CG)23-like shadow lineages such as ST65, ST86, ST412 and ST268, which are consistently associated with metastatic disease and adverse outcomes in otherwise healthy hosts. Synthesizing clinical, genomic, and epidemiological evidence, this perspective proposes an updated K. pneumoniae pathotype framework that integrates clonality, antimicrobial resistance (AMR), and epidemiological context; advocates tiered laboratory diagnostics; and cautions against indiscriminate hvKp labelling to safeguard antimicrobial stewardship and informed clinical decision-making.
Insights
Hypervirulent Klebsiella pneumoniae (hvKp) strains do not always cause higher mortality. True hypervirulence depends on specific lineages, not just virulence genes, impacting clinical risk assessment.
Area of Science:
- Microbiology
- Infectious Diseases
- Genomics
Background:
- The global rise of hypervirulent Klebsiella pneumoniae (hvKp) is concerning due to invasive infections and mortality.
- However, evidence suggests a paradox: some hvKp strains lack high mortality, while others with fewer markers are comparable to multidrug-resistant strains.
- Traditional methods may overemphasize classical hypervirulent lineages associated with metastatic complications.
Purpose of the Study:
- To address the definitional crisis of hvKp, where virulence gene carriage doesn't always predict clinical outcomes.
- To propose an updated framework for K. pneumoniae pathotypes.
- To advocate for refined laboratory diagnostics and cautious hvKp labeling.
Main Methods:
- Systematic reviews and meta-analyses of existing data.
- Genome-wide association studies (GWAS).
- Phenotypic analyses focusing on virulence factors like capsular polysaccharide.
- Synthesis of clinical, genomic, and epidemiological evidence.
Main Results:
- Genotypically defined hvKp clones with fewer virulence markers show mortality rates similar to multidrug-resistant K. pneumoniae.
- Capsular polysaccharide is a key virulence driver in carbapenem-resistant hvKp, independent of plasmids.
- Only 37.3% of carbapenem-resistant hvKp with plasmid markers showed true hypervirulence.
- Specific lineages (e.g., K1/K2 ST23 and related shadow lineages) are consistently linked to metastatic disease.
Conclusions:
- Virulence gene carriage alone is insufficient to define hvKp or predict clinical outcomes.
- Lineage-specific risk is crucial, exemplified by ST23 and its related lineages.
- An updated K. pneumoniae pathotype framework integrating clonality, antimicrobial resistance (AMR), and epidemiology is needed.
- Tiered diagnostics and careful labeling of hvKp are essential for antimicrobial stewardship and clinical decision-making.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Atypical Pneumonia
Determinants of Bacterial Pathogenicity and Virulence
Mechanism of Antibiotic Resistance in MRSA
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
